Beam Therapeutics Stock Price History

BEAM Stock  USD 28.30  0.93  3.40%   
Below is the normalized historical share price chart for Beam Therapeutics extending back to February 06, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Beam Therapeutics stands at 28.30, as last reported on the 3rd of December, with the highest price reaching 28.63 and the lowest price hitting 27.00 during the day.
IPO Date
6th of February 2020
200 Day MA
26.6648
50 Day MA
24.601
Beta
1.862
 
Covid
If you're considering investing in Beam Stock, it is important to understand the factors that can impact its price. Beam Therapeutics appears to be not too volatile, given 3 months investment horizon. Beam Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0809, which signifies that the company had a 0.0809% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Beam Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Beam Therapeutics' mean deviation of 3.14, and Risk Adjusted Performance of 0.0384 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Beam Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 3rd of December 2024, Other Stockholder Equity is likely to grow to about 2.3 B, while Liabilities And Stockholders Equity is likely to drop about 794.1 M. . At this time, Beam Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 3rd of December 2024, Price To Book Ratio is likely to grow to 2.25, while Price Earnings Ratio is likely to drop (16.64). Beam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0809

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsBEAM
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.16
  actual daily
37
63% of assets are more volatile

Expected Return

 0.34
  actual daily
6
94% of assets have higher returns

Risk-Adjusted Return

 0.08
  actual daily
6
94% of assets perform better
Based on monthly moving average Beam Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beam Therapeutics by adding it to a well-diversified portfolio.
Price Book
2.8641
Enterprise Value Ebitda
(7.03)
Price Sales
6.482
Shares Float
64.8 M
Wall Street Target Price
49.2

Beam Therapeutics Stock Price History Chart

There are several ways to analyze Beam Stock price data. The simplest method is using a basic Beam candlestick price chart, which shows Beam Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 11, 202430.35
Lowest PriceOctober 25, 202421.55

Beam Therapeutics December 3, 2024 Stock Price Synopsis

Various analyses of Beam Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Beam Stock. It can be used to describe the percentage change in the price of Beam Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Beam Stock.
Beam Therapeutics Price Rate Of Daily Change 1.03 
Beam Therapeutics Price Action Indicator 0.95 
Beam Therapeutics Price Daily Balance Of Power 0.57 

Beam Therapeutics December 3, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Beam Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Beam Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Beam Stock and then apply it to test your longer-term investment strategies against Beam.

Beam Stock Price History Data

The price series of Beam Therapeutics for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 has a statistical range of 8.8 with a coefficient of variation of 7.22. The prices are distributed with arithmetic mean of 24.73. The median price for the last 90 days is 24.49. The company had 2:1 stock split on October 26, 1990. Beam Therapeutics issued dividends on Feb 4, 2014.
OpenHighLowCloseVolume
12/03/2024
 27.33  28.63  27.00  28.30 
12/02/2024 27.33  28.63  27.00  28.30  1,037,424 
11/29/2024 27.41  28.10  27.00  27.37  568,879 
11/27/2024 26.09  27.30  26.09  27.20  646,814 
11/26/2024 26.47  27.19  25.09  25.84  716,259 
11/25/2024 25.94  26.90  25.59  26.65  1,217,320 
11/22/2024 23.60  25.43  23.18  25.05  1,187,273 
11/21/2024 24.53  24.71  23.33  23.58  1,010,234 
11/20/2024 25.25  25.87  24.39  24.49  1,212,095 
11/19/2024 23.75  25.39  23.67  25.29  1,154,024 
11/18/2024 24.80  25.05  23.72  24.12  1,281,327 
11/15/2024 26.44  26.44  23.62  24.05  2,258,965 
11/14/2024 27.55  27.82  26.20  26.31  918,252 
11/13/2024 28.22  28.91  27.15  27.50  822,497 
11/12/2024 29.69  30.66  27.38  27.94  1,589,932 
11/11/2024 27.58  32.29  27.50  30.35  1,852,256 
11/08/2024 25.88  27.38  25.68  27.06  1,265,887 
11/07/2024 26.56  27.17  25.60  26.10  934,888 
11/06/2024 26.00  27.30  25.24  26.62  2,020,042 
11/05/2024 21.62  24.79  21.46  23.93  2,296,855 
11/04/2024 22.75  24.95  22.52  24.36  1,388,907 
11/01/2024 22.30  23.11  22.05  22.93  778,406 
10/31/2024 22.61  22.61  21.86  21.91  1,127,633 
10/30/2024 21.93  22.70  21.79  22.50  849,880 
10/29/2024 22.35  22.35  21.85  22.17  619,016 
10/28/2024 21.90  22.74  21.68  22.35  569,366 
10/25/2024 22.18  22.32  21.50  21.55  1,959,093 
10/24/2024 22.04  22.14  21.14  22.09  927,760 
10/23/2024 22.63  22.76  21.76  21.82  1,394,389 
10/22/2024 23.00  23.09  22.44  22.74  969,629 
10/21/2024 23.36  23.46  22.67  23.15  1,025,939 
10/18/2024 24.40  24.49  23.15  23.65  1,175,291 
10/17/2024 26.16  26.43  23.68  24.35  1,619,738 
10/16/2024 26.30  27.42  25.75  26.69  1,467,033 
10/15/2024 26.60  26.87  25.98  26.34  876,973 
10/14/2024 24.65  26.88  24.53  26.59  1,370,911 
10/11/2024 22.72  24.87  22.72  24.72  882,818 
10/10/2024 23.05  23.34  22.67  23.03  513,670 
10/09/2024 23.22  23.72  22.70  23.44  489,058 
10/08/2024 23.30  23.53  22.95  23.26  524,273 
10/07/2024 23.17  23.51  22.99  23.39  826,214 
10/04/2024 23.50  23.73  22.95  23.41  477,400 
10/03/2024 23.17  23.44  22.48  22.94  700,399 
10/02/2024 23.28  23.60  23.05  23.50  610,986 
10/01/2024 24.40  24.40  23.12  23.41  909,222 
09/30/2024 24.94  25.24  24.22  24.50  845,782 
09/27/2024 25.60  25.78  24.73  25.05  653,350 
09/26/2024 25.19  25.95  24.64  25.12  489,378 
09/25/2024 24.76  25.35  24.25  24.50  861,167 
09/24/2024 24.74  24.85  24.21  24.77  1,047,181 
09/23/2024 25.81  25.83  24.47  24.72  1,034,023 
09/20/2024 25.62  26.00  25.28  25.65  1,927,248 
09/19/2024 26.66  26.67  25.87  26.04  633,823 
09/18/2024 25.34  27.04  24.96  25.51  787,686 
09/17/2024 26.13  26.58  25.18  25.58  831,426 
09/16/2024 26.39  26.54  25.49  25.62  590,859 
09/13/2024 24.88  26.34  24.72  26.30  944,750 
09/12/2024 24.23  24.67  23.45  24.40  531,548 
09/11/2024 23.65  24.17  23.18  24.12  503,698 
09/10/2024 23.37  23.90  23.06  23.65  457,124 
09/09/2024 23.32  23.86  23.17  23.40  681,754 

About Beam Therapeutics Stock history

Beam Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Beam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Beam Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Beam Therapeutics stock prices may prove useful in developing a viable investing in Beam Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding77.2 M56.2 M
Net Loss-234.2 M-245.9 M

Beam Therapeutics Quarterly Net Working Capital

779.29 Million

Beam Therapeutics Stock Technical Analysis

Beam Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Beam Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Beam Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Beam Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Beam Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Beam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Beam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Beam Therapeutics is a strong investment it is important to analyze Beam Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beam Therapeutics' future performance. For an informed investment choice regarding Beam Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.58)
Revenue Per Share
4.273
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.09)
Return On Equity
(0.18)
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.